<p>A) CHP-212 and SK-N-AS cells were treated with 5nM of the mTOR inhibitors Everolimus or 250nM AZD8055 for 1 hour. Then, cells were lysed and analysed by Western blot. B) All indicated cell lines were left untreated or treated with indicated concentrations of Everolimus for 96 hours. Next, cell growth was measured by Cell Titer Glo according to the manufacturer’s instructions C) Same as B) but the mTOR inhibitor AZD8055 was used instead. D) NRAS mutant and wild-type cell lines were incubated with indicated concentrations of Everolimus for 72 hours. Then, apoptosis was determined by Annexin V and PI staining.</p
<p>(a) Inhibitory effects of rapamycinorAZD2014 combined with 2-DGon cell proliferation in A549 cell...
AbstractObjectiveTo investigate the effect and mechanism of inhibitor everolimus on EGFR-TKI resista...
<p>A. Representative image of immunoblotting for p-mTOR in HaCaT cell non-exposed or exposed for 1 a...
<p>(<b>A</b>) The indicated cell lines were assessed for viability on the indicated days using CellT...
<p>A) CHP-212 and SK-N-AS cells were treated with indicated concentrations of AZD6244, MEK162, Evero...
<div><p>BCR-ABL+ (BV, PH, KW, CM, BV und DW), TEL-ABL+ (VG) and BCR-ABL- (HP, KR, RL, CR und SK) LTC...
High-risk neuroblastoma remains lethal in about 50% of patients despite multimodal treatment. Recent...
High-risk neuroblastoma remains lethal in about 50% of patients despite multimodal treatment. Recent...
<p><b>A) and B)</b> RD cells were treated for 24h with 1 µM DOX and/or 1 µM everolimus (ever; respec...
mTOR (mechanistic target of rapamycin) functions as the central regulator for cell proliferation, gr...
<p>(<b>A</b>) The indicated cells were treated for 24 hrs. with rapamycin or BEZ235 and immunoblotte...
<p>The indicated cell lines were treated with the allosteric and catalytic mTOR inhibitors (rapamyci...
Background/Aim: Tumors exhibiting constitutively activated PI(3) K/Akt/mTOR signaling are hypersensi...
<p>(a) A549 cells were treated with AZD2014 and rapamycin. (b) PC-9 cells were treated with AZD2014 ...
Phosphorylated (pi-) protein kinase B (AKT) is commonly expressed in nasopharyngeal carcinoma (NPC) ...
<p>(a) Inhibitory effects of rapamycinorAZD2014 combined with 2-DGon cell proliferation in A549 cell...
AbstractObjectiveTo investigate the effect and mechanism of inhibitor everolimus on EGFR-TKI resista...
<p>A. Representative image of immunoblotting for p-mTOR in HaCaT cell non-exposed or exposed for 1 a...
<p>(<b>A</b>) The indicated cell lines were assessed for viability on the indicated days using CellT...
<p>A) CHP-212 and SK-N-AS cells were treated with indicated concentrations of AZD6244, MEK162, Evero...
<div><p>BCR-ABL+ (BV, PH, KW, CM, BV und DW), TEL-ABL+ (VG) and BCR-ABL- (HP, KR, RL, CR und SK) LTC...
High-risk neuroblastoma remains lethal in about 50% of patients despite multimodal treatment. Recent...
High-risk neuroblastoma remains lethal in about 50% of patients despite multimodal treatment. Recent...
<p><b>A) and B)</b> RD cells were treated for 24h with 1 µM DOX and/or 1 µM everolimus (ever; respec...
mTOR (mechanistic target of rapamycin) functions as the central regulator for cell proliferation, gr...
<p>(<b>A</b>) The indicated cells were treated for 24 hrs. with rapamycin or BEZ235 and immunoblotte...
<p>The indicated cell lines were treated with the allosteric and catalytic mTOR inhibitors (rapamyci...
Background/Aim: Tumors exhibiting constitutively activated PI(3) K/Akt/mTOR signaling are hypersensi...
<p>(a) A549 cells were treated with AZD2014 and rapamycin. (b) PC-9 cells were treated with AZD2014 ...
Phosphorylated (pi-) protein kinase B (AKT) is commonly expressed in nasopharyngeal carcinoma (NPC) ...
<p>(a) Inhibitory effects of rapamycinorAZD2014 combined with 2-DGon cell proliferation in A549 cell...
AbstractObjectiveTo investigate the effect and mechanism of inhibitor everolimus on EGFR-TKI resista...
<p>A. Representative image of immunoblotting for p-mTOR in HaCaT cell non-exposed or exposed for 1 a...